MARKET

XBI

XBI

SPDR® S&P Biotech ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

90.03
-1.94
-2.11%
After Hours: 89.70 -0.33 -0.37% 19:58 01/21 EST
OPEN
91.19
PREV CLOSE
91.97
HIGH
93.26
LOW
89.87
VOLUME
21.25M
TURNOVER
--
52 WEEK HIGH
174.79
52 WEEK LOW
89.87
TOTAL ASSET
7.11B
YTD YIELD
11.79%
1D
5D
1M
3M
1Y
5Y
Big-Tech Earnings Jitters Mount as Pandemic Darlings Get Crushed
Bloomberg · 11h ago
‘Anti-ARKK’ ETF Amasses $234 Million as Cathie Wood Struggles
Bloomberg · 13h ago
Stock Jitters Grow as $3.3 Trillion of Options Expires in a Day
Bloomberg · 15h ago
Bitcoin Mining’s Hearing in U.S. House Questions Power Usage
Bloomberg · 16h ago
Fund in Abu Dhabi Tracking Saudi Shares Is a First for Gulf ETFs
Bloomberg · 17h ago
Gold Wavers After Reaching Two-Month High as Dollar Rebounds
Bloomberg · 1d ago
SEC Rejects Bitcoin ETF Plan From Anthony Scaramucci’s Skybridge Capital
Bloomberg · 1d ago
Quant ETFs With $564 Million Switch to Become Actively Managed
Bloomberg · 1d ago
More
No Data
Learn about the latest financial forecast of XBI. Analyze the recent business situations of SPDR® S&P Biotech ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
08/31/2020
10 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
0.2239%
--
1-Week
-1.3327%
--
1-Month
-6.5522%
--
3-Month
2.3267%
--
6-Month
18.1541%
--
YTD
11.7862%
--
1-Year
35.5354%
--
3-Year
8.0603%
--
5-Year
8.1538%
--
10-Year
19.4995%
--
Since Inception
13.9739%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
SPDR® S&P Biotech ETF
Risk
Low risk
Inception Date
2006-01-31
Benchmark
NASDAQ Composite CR
Advisor Company
State Street Global Advisors Ltd
Custodian
State Street Bank & Trust Co
Manager
Feehily/Schneider/Donofrio